Cannabist Exits Denver Cultivation as Wind-Down Reaches Colorado

The Cannabist Company will permanently shut its Denver cultivation and manufacturing plant and cut 50 jobs, the clearest sign yet that the multistate operator’s court-supervised liquidation has reached Colorado — even as a buyer lines up for the stores that plant once supplied.

The Cannabist Company told state labor officials it will close the facility at 4750 Nome Street in a notice filed July 14, 2026 with the Colorado Department of Labor and Employment. The layoffs begin September 11, 2026, and affected workers keep base pay and benefits for 60 days; the company said the separations are permanent. The site was once home to Medicine Man, one of Colorado’s best-known dispensary-and-grow operations, which Columbia Care — Cannabist’s former name — acquired in 2021.

A buyer for the stores, not the grow

Days after the closure notice, on July 20, 2026, Vireo Growth agreed to acquire Cannabist’s operations across five states — Colorado, Illinois, Massachusetts, New Jersey and West Virginia — for up to $35 million, split between $18.75 million in cash at closing and $16.25 million in seller notes. In Colorado, Vireo picks up eight dispensaries.

What it does not pick up is much cultivation. Across all five markets, the deal adds just one grow and one production site — a plain signal that in today’s market, the plants themselves carry little value. That is why the Denver facility is being shut rather than sold.

Vireo, which recently entered Pennsylvania and agreed to buy a Nevada operator, cast the purchase as consolidation, with Chief Executive John Mazarakis calling it part of a “disciplined and strategic approach to industry consolidation.” The transaction would lift Vireo to roughly 230 dispensaries across 15 states. It is set to close in stages through 2026 and into 2027, subject to approval by the Canadian court overseeing Cannabist’s restructuring and by state cannabis regulators.

How Cannabist got here

Cannabist made industry history in May 2026 as the first cannabis multistate operator to win federal bankruptcy protection in the United States. Because marijuana remains federally illegal, US-based cannabis companies have been shut out of Chapter 11. Cannabist, a Canadian-incorporated holding company, took another route: it opened creditor protection in Canada under the Companies’ Creditors Arrangement Act on March 24, 2026, then asked a Delaware court to recognize that proceeding under Chapter 15, filed the next day. Judge Brendan Shannon granted recognition on May 9, 2026, over the lone objection of secured creditor East West (EASTWEST.BO ) Bank. The ruling matters beyond Cannabist: it hands other distressed operators with Canadian parent companies a template for reaching US bankruptcy protection that plant-touching businesses have long been denied.

Court filings put the company’s obligations at about $270 million owed to lenders and the Internal Revenue Service, including roughly $179 million in senior secured notes. The unraveling began when Cannabist skipped a December 31, 2025 interest payment, triggering a default once the grace period lapsed and a string of forbearance deals with noteholders. Compounding the strain was a dispute with the IRS over tens of millions in back taxes, tied to the federal rule that bars cannabis companies from deducting ordinary business expenses.

The company has been selling itself off in pieces. Its Virginia business went to Parma Holdco for $130 million in a sale that closed in February 2026, after Curaleaf walked away from an earlier deal for the assets in December 2025. Ohio is under agreement to Holistic Industries for $47 million, expected to close in the third quarter of 2026, and Delaware is set to fetch $16.5 million. Cannabist also surrendered its New York medical license and wound down Pennsylvania.

Why the grow went dark

The Denver closure says as much about Colorado as it does about Cannabist. Wholesale flower prices have fallen roughly 65% from their 2021 peak — from about $1,700 a pound to under $600 — according to state Department of Revenue data, gutting the economics of growing cannabis to stock your own shelves. Vertically integrated operators that once prized their cultivation are now shutting grows and buying product on the open market instead.

Cannabist is not alone in retreating. PharmaCann, which owns the LivWell chain, closed its own Denver cultivation and processing facility earlier in 2026, cutting 132 jobs.

For the 50 Denver workers, the clock now runs to September 2026. For Cannabist, what remains is procedure: closing the Vireo and Ohio sales, routing the proceeds to creditors through the Canadian plan, and finishing an exit that will retire one of the industry’s original multistate operators.